글로벌 혈관종 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 혈관종 치료 시장

혈관종 치료 시장은 2021년에서 2028년까지의 예측 기간 동안 3.7%의 시장 성장을 목격할 것으로 예상됩니다. 혈관종 치료 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 뇌 질환 유병률이 증가함에 따라 혈관종 치료 시장 성장이 가속화되고 있습니다.

혈관종은 일반적으로 출생 후 1주차와 2주차에 나타나는 붉은색 모반을 말합니다. 혈관으로 구성되어 피부에 고무 같은 융기처럼 보이는 양성 또는 비암성 종양입니다. 종양은 얼굴, 가슴, 두피, 등에 발생하며 일부는 신체의 근육, 뼈 또는 내부 장기에 나타납니다.

전 세계적으로 유아와 어린이의 혈관종 발병률이 증가하는 것은 혈관종 치료 시장 성장을 견인하는 주요 요인 중 하나입니다. 베타 차단제 약물, 항염제 등과 같은 약물 에 대한 수요 증가 와 신체 내부 장기에 존재하는 종양을 제거하는 최소 침습적 시술의 증가는 시장 성장을 가속화합니다. 정부와 공공 기관의 연구 개발 활동 수와 성장하는 이니셔티브의 증가는 시장에 더 많은 영향을 미칩니다. 또한 투자 급증, 의료비 지출 증가, 인구 증가 및 기술 개발 은 혈관종 치료 시장에 긍정적인 영향을 미칩니다. 더욱이 새로운 약물에 대한 높은 수요와 새로운 약물 및 치료법의 도입은 2021년에서 2028년의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

On the other hand, high cost associated with the treatment and side effects associated with surgical laser procedures are expected to obstruct the market growth. Stringent approval policies for new therapies are projected to challenge the hemangiomas treatment market in the forecast period of 2021-2028.

This hemangiomas treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info hemangiomas treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Hemangiomas Treatment Market Scope and Market Size

The hemangiomas treatment market is segmented on the basis of drug class, type, diagnosis, treatment type, route of administration, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of drug class, the hemangiomas treatment market is segmented into beta blocker medication, anti-inflammatory medication and others.
• On the basis of type, the hemangiomas treatment market is segmented into external hemangioma and dinternal hemangioma. External Hemangioma is further segmented into Capillary Hemangioma, Cavernous Hemangioma, Lobular Capillary Hemangioma, Compound Hemangioma and Others. Internal Hemangioma is further segmented into Muscle Hemangioma, Bone Hemangioma and Spinal Hemangioma.
• On the basis of diagnosis, the hemangiomas treatment market is segmented into x ray, computerized tomography (CT) Scans, biopsy, angiogram and others.
• On the basis of treatment type, the hemangiomas treatment market is segmented into medication, surgery, laser treatment and others.
• On the basis of route of administration, the hemangiomas treatment market is segmented into oral, injectable and others.
• On the basis of end users, the hemangiomas treatment market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the hemangiomas treatment market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Hemangiomas Treatment Market Country Level Analysis

The hemangiomas treatment market is analyzed and market size information is provided by country, drug class, type, diagnosis, treatment type, route of administration, end user and distribution channel as referenced above.

The countries covered in the global hemangiomas treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the hemangiomas treatment market due to the increase in infantile hemangioma, and an increase in adult hemangioma cases within the region. Europe is expected to witness high growth during the forecast period of 2021 to 2028 because of the increase in minimally invasive surgeries and availability of drugs in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The hemangiomas treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Hemangiomas Treatment Market Share Analysis

The hemangiomas treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related hemangiomas treatment market.

혈관종 치료 시장 보고서에 포함된 주요 기업은 Pierre Fabre Group, BIOLASE, Inc., Bausch Health, Cutera, Teva Pharmaceutical Industries Ltd., IRIDEX Corporation, Alma Lasers Ltd, LINLINE Medical Systems Ltd., Merck & Co., Inc., AbbVie Inc.,., ALLERGAN, Akorn, Pfizer Inc. 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-50413